Menendez slams Hugin in new ad
Hits pharma executive for ‘ripping off cancer patients’
Tag: Celgene
Booker calls news that Hugin discounted cancer drug in Russia a ‘mortal blow’
Senator says GOP candidate drove up drug prices
Menendez slams Hugin for discounting drugs in Russia
PENNINGTON - U.S. Senator Bob Menendez today called Bob Hugin’s decision to sell a life-saving cancer drug in Russia for almost half the U.S. price “outrageous” and “despicable.” The comments by the New Jersey Democrat came a day after NJ.com reported that Celgene, the pharmaceutical company Hugin ran, cut the price of Revlimid by about 45% in Russia while raising the cost of the same drug in the United States
Hugin doubled price of live-saving cancer drug, report says
Group finds GOP Senate candidate blocked generic drug, made $140 million profit by keeping prices high
Super PAC spends $1.5 million attacking Hugin
GOP Senate candidate slammed on doubling cost of cancer drug
Menendez campaign launches new website
Site devoted to attacking Hugin over Celgene
Hugin attends Romney summit in Utah
GOP Senate candidate kept his attendance quiet
Menendez: Hugin’s money could make a dent
Slams GOP rival for ‘sucking the blood of cancer patients’
Hugin staffer named to Mendham post
Neibart replaced Blood, who resigned after Facebook controversy
Ex-rival vouches for Hugin’s pro-life credentials
A longtime New Jersey pro-life advocate says that he’s satisfied with U.S. Senate candidate Bob Hugin’s position on abortion. “I know that he opposes late term abortion and will support any judges proposed by President Trump,” said Richard Pezzullo, who dropped out of the race this week to endorse Hugin. The Hugin campaign clarified Pezzullo’s depiction on the new candidate’s views. “Bob opposes late-term abortions unless the life of the mother